NONOF
NOVO NORDISK A/S B NEWstockOTC
EODNov 18, 2026
39.52USD-2.009%(-0.81)8,841
NONOF News
Lilly's retatrutide beats Novo’s Ozempic in late-stage trial ·
Seeking Alpha
Lilly wins EU backing for Foundayo weight-loss pill ·
Seeking Alpha
GLP-1s are linked to lower psychiatric hospitalizations: study ·
Seeking Alpha
Pharma lobby group sues Trump administration over MFN pricing ·
Seeking Alpha
Lilly says Zepbound at higher doses tops Novo’s Wegovy HD ·
Seeking Alpha
Novo CEO says Ozempic maker is open to direct U.S. listing: FT ·
Seeking Alpha
Novo eyes hair-loss market as Ozempic maker looks to diversify ·
Seeking Alpha